BEQ inquiry from health authority [Study As­sess­ment]

posted by Aymanmy – Jordan, 2019-12-18 08:51 (488 d 10:53 ago) – Posting: # 20990
Views: 2,680

Hi colleagues
Recently we submitted a BE study to EU, and we recieved an inquiry about in some subjects (5 out of 60) the LLOQ is more than 5% of the Cmax, plz need to know how can we reply about this case since the method was applicable for more than 90% of the subjects in the study and the LLOQ is actually less than 5% of the average Cmax, and no detected concentrations in the predose samples for these subjects.
Kind regards


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 19 (0 registered, 19 guests [including 5 identified bots]).
Forum time: Monday 20:44 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5